These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26024243)

  • 1. Swallowed glucocorticoid therapy for eosinophilic esophagitis in children does not suppress adrenal function.
    Philla KQ; Min SB; Hefner JN; Howard RS; Reinhardt BJ; Nazareno LG; Vogt KS
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1101-6. PubMed ID: 26024243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal Insufficiency after Chronic Swallowed Glucocorticoid Therapy for Eosinophilic Esophagitis.
    Golekoh MC; Hornung LN; Mukkada VA; Khoury JC; Putnam PE; Backeljauw PF
    J Pediatr; 2016 Mar; 170():240-5. PubMed ID: 26687577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis.
    Andreae DA; Hanna MG; Magid MS; Malerba S; Andreae MH; Bagiella E; Chehade M
    Am J Gastroenterol; 2016 Aug; 111(8):1187-97. PubMed ID: 27325220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal suppression in children treated with swallowed fluticasone and oral viscous budesonide for eosinophilic esophagitis.
    Ahmet A; Benchimol EI; Goldbloom EB; Barkey JL
    Allergy Asthma Clin Immunol; 2016; 12():49. PubMed ID: 27766109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, comparative effectiveness trial of cow's milk elimination and swallowed fluticasone for pediatric eosinophilic esophagitis.
    Kruszewski PG; Russo JM; Franciosi JP; Varni JW; Platts-Mills TA; Erwin EA
    Dis Esophagus; 2016 May; 29(4):377-84. PubMed ID: 25721813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children With Eosinophilic Esophagitis.
    Fable JM; Fernandez M; Goodine S; Lerer T; Sayej WN
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):26-32. PubMed ID: 28489670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.
    Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Tylicki AE; Shoyoye SO; Martin CF; Galanko JA; Baron JA; Shaheen NJ
    Gastroenterology; 2019 Jul; 157(1):65-73.e5. PubMed ID: 30872104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcomes for eosinophilic esophagitis in children with esophageal atresia.
    Chan LJ; Tan L; Dhaliwal J; Briglia F; Clarkson C; Krishnan U
    Dis Esophagus; 2016 Aug; 29(6):563-71. PubMed ID: 25872589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis.
    Kuchen T; Straumann A; Safroneeva E; Romero Y; Bussmann C; Vavricka S; Netzer P; Reinhard A; Portmann S; Schoepfer AM
    Allergy; 2014 Sep; 69(9):1248-54. PubMed ID: 24894658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis.
    Albert D; Heifert TA; Min SB; Maydonovitch CL; Baker TP; Chen YJ; Moawad FJ
    Dig Dis Sci; 2016 Jul; 61(7):1996-2001. PubMed ID: 27093866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilic esophagitis--treatment of eosinophilic esophagitis with drugs: corticosteroids.
    von Arnim U; Malfertheiner P
    Dig Dis; 2014; 32(1-2):126-9. PubMed ID: 24603395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study.
    Dellon ES; Rusin S; Gebhart JH; Covey S; Higgins LL; Beitia R; Speck O; Woodward K; Woosley JT; Shaheen NJ
    Am J Gastroenterol; 2015 Jun; 110(6):821-7. PubMed ID: 25781367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal Suppression in Children Treated With Oral Viscous Budesonide for Eosinophilic Esophagitis.
    Harel S; Hursh BE; Chan ES; Avinashi V; Panagiotopoulos C
    J Pediatr Gastroenterol Nutr; 2015 Aug; 61(2):190-3. PubMed ID: 25950088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis.
    Alexander JA; Jung KW; Arora AS; Enders F; Katzka DA; Kephardt GM; Kita H; Kryzer LA; Romero Y; Smyrk TC; Talley NJ
    Clin Gastroenterol Hepatol; 2012 Jul; 10(7):742-749.e1. PubMed ID: 22475741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registry.
    Laserna-Mendieta EJ; Navarro P; Casabona-Francés S; Savarino EV; Amorena E; Pérez-Martínez I; Guagnozzi D; Blas-Jhon L; Betoré E; Guardiola-Arévalo A; Pellegatta G; Krarup AL; Perello A; Barrio J; Gutiérrez-Junquera C; Teruel Sánchez-Vegazo C; Fernández-Fernández S; Naves JE; Oliva S; Rodríguez-Oballe JA; Carrión S; Espina S; Llorente Barrio M; Masiques-Mas ML; Dainese R; Feo-Ortega S; Martín-Dominguez V; Fernández-Pacheco J; Pérez-Fernández MT; Ghisa M; Maniero D; Nantes-Castillejo Ó; Nicolay-Maneru J; Suárez A; Maray I; Llerena-Castro R; Ortega-Larrodé A; Alcedo J; Granja Navacerrada A; Racca F; Santander C; Arias Á; Lucendo AJ;
    United European Gastroenterol J; 2024 Jun; 12(5):585-595. PubMed ID: 38284792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia.
    Moawad FJ; Veerappan GR; Dias JA; Baker TP; Maydonovitch CL; Wong RK
    Am J Gastroenterol; 2013 Mar; 108(3):366-72. PubMed ID: 23399553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood eosinophils and other non-invasive biomarkers can monitor treatment response in eosinophilic oesophagitis.
    Schlag C; Miehlke S; Heiseke A; Brockow K; Krug A; von Arnim U; Straumann A; Vieth M; Bussmann C; Mueller R; Greinwald R; Bajbouj M
    Aliment Pharmacol Ther; 2015 Nov; 42(9):1122-30. PubMed ID: 26314389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active eosinophilic esophagitis is associated with impaired elimination of budesonide by cytochrome P450 3A enzymes.
    Dilger K; Lopez-Lazaro L; Marx C; Bussmann C; Straumann A
    Digestion; 2013; 87(2):110-7. PubMed ID: 23364258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative long-term treatment of children with eosinophilic esophagitis.
    Levine J; Lai J; Edelman M; Schuval SJ
    Ann Allergy Asthma Immunol; 2012 May; 108(5):363-6. PubMed ID: 22541409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological Response to Fluticasone Propionate in Patients With Eosinophilic Esophagitis Is Associated With Improved Functional Esophageal Mucosal Integrity.
    van Rhijn BD; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
    Am J Gastroenterol; 2015 Sep; 110(9):1289-97. PubMed ID: 26303134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.